Profile picture of Reuters
U.S. FDA declines to approve Spectrum's lung cancer drug: Spectrum Pharmaceuticals Inc (SPPI.O) said on Friday the U.S. Food and Drug Administration (FDA) ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-spectrum-pharmaceuticals-lung-cancer-drug-2022-11-25/
U.S. FDA declines to approve Spectrum's lung cancer drug